Pink SheetPodium policy is back at the US Food and Drug Administration. The phrase was coined decades ago by agency critics, generally conservative politicians or industry officials, who bristled at what they s
Pink SheetUS FDA Commissioner Martin Makary continued to concentrate institutional power around his office by giving Center for Biologics Evaluation and Research director Vinay Prasad more authority. Prasad add
Pink SheetVinay Prasad, the US Food and Drug Administration’s new director of the Center for Biologics Evaluation and Research, said his role in product reviews will be no different than previous center directo
Pink SheetConfused and alarmed stakeholders worry that Health and Human Services Secretary Robert F. Kennedy Jr. usurped a role long played by the US Centers for Disease Control and Prevention and its external